Standard InChI: InChI=1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34) (Source: PubChem)
IUPAC Name: 1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (Source: PubChem)
PubChem CID: 25102847 (Source: PubChem)
SMILES String: COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F (Source: PubChem)
Connectivity SMILES string: COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F (Source: PubChem)
Standard InChIKey: ONIQOQHATWINJY-UHFFFAOYSA-N (Source: PubChem)
CAS Registry Number: 849217-68-1 (Source: PubChem)
ChEBI ID: CHEBI:72317 (Source: PubChem)
ChEMBL ID: CHEMBL2105717 (Source: PubChem)
CompTox Dashboard Compound ID: DTXCID40156459 (Source: PubChem)
CompTox Dashboard Substance ID: DTXSID10233968 (Source: PubChem)
Wikidata ID: Q795057 (Source: PubChem)
WHO ATC Classification Drug Code: L01EX07 (Source: ChEMBL)
WHO ATC Classification Drug Name: Cabozantinib (Source: ChEMBL)
British National Formulary: Cabozantinib (Source: ChEMBL)
Connectivity SMILES string: COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC (Source: ChEMBL)
International Nonproprietary Name: Cabozantinib (Source: ChEMBL)
Merck Index Name: Cabozantinib (Source: ChEMBL)
Preferred Name: CABOZANTINIB (Source: ChEMBL)
Standard InChI: InChI=1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34) (Source: ChEMBL)
Standard InChIKey: ONIQOQHATWINJY-UHFFFAOYSA-N (Source: ChEMBL)
US Adopted Name: Cabozantinib (Source: ChEMBL)